These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16158827

  • 1. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
    Kosugi S, Matsumoto M, Ohtani Y, Take H, Ishizashi H, Fujimura Y, Kuyama J.
    Int J Hematol; 2005 Jun; 81(5):433-6. PubMed ID: 16158827
    [Abstract] [Full Text] [Related]

  • 2. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X, Pallera AM, Goodnough LT, Sadler JE, Blinder MA.
    Ann Intern Med; 2003 Jan 21; 138(2):105-8. PubMed ID: 12529092
    [Abstract] [Full Text] [Related]

  • 3. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
    Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP.
    Blood; 2005 Sep 15; 106(6):1932-7. PubMed ID: 15933059
    [Abstract] [Full Text] [Related]

  • 4. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M.
    Thromb Haemost; 2009 Feb 15; 101(2):233-8. PubMed ID: 19190804
    [Abstract] [Full Text] [Related]

  • 5. Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura.
    Ann Intern Med; 2003 Jan 21; 138(2):I38. PubMed ID: 12529111
    [No Abstract] [Full Text] [Related]

  • 6. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Yomtovian R, Niklinski W, Silver B, Sarode R, Tsai HM.
    Br J Haematol; 2004 Mar 21; 124(6):787-95. PubMed ID: 15009067
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.
    Am J Hematol; 2004 Oct 21; 77(2):171-6. PubMed ID: 15389904
    [Abstract] [Full Text] [Related]

  • 9. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
    Ling HT, Field JJ, Blinder MA.
    Am J Hematol; 2009 Jul 21; 84(7):418-21. PubMed ID: 19507208
    [Abstract] [Full Text] [Related]

  • 10. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ.
    Br J Haematol; 2007 Feb 21; 136(3):451-61. PubMed ID: 17233847
    [Abstract] [Full Text] [Related]

  • 11. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Hong H, Aoyama Y, Yamamura R, Ohta T, Mugitani A, Yamane T, Hino M, Matsumoto M, Fujimura Y.
    Rinsho Ketsueki; 2006 Dec 21; 47(12):1528-32. PubMed ID: 17233471
    [Abstract] [Full Text] [Related]

  • 12. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
    Hagel S, Jantsch J, Budde U, Kalden JR, Eckardt KU, Veelken R.
    Thromb Haemost; 2008 Jul 21; 100(1):151-3. PubMed ID: 18612551
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura.
    Tsai HM, Shulman K.
    Eur J Haematol; 2003 Mar 21; 70(3):183-5. PubMed ID: 12605663
    [Abstract] [Full Text] [Related]

  • 15. Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.
    Galbusera M, Bresin E, Noris M, Gastoldi S, Belotti D, Capoferri C, Daina E, Perseghin P, Scheiflinger F, Fakhouri F, Grünfeld JP, Pogliani E, Remuzzi G.
    Blood; 2005 Aug 01; 106(3):925-8. PubMed ID: 15827129
    [Abstract] [Full Text] [Related]

  • 16. Rituximab therapy for refractory thrombotic thrombocytopenic purpura.
    Gutterman LA, Kloster B, Tsai HM.
    Blood Cells Mol Dis; 2002 Aug 01; 28(3):385-91. PubMed ID: 12367582
    [Abstract] [Full Text] [Related]

  • 17. Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.
    Herbei L, Venugopal P.
    Clin Adv Hematol Oncol; 2006 Mar 01; 4(3):215-7; discussion 217-8. PubMed ID: 16728931
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM, Uener J, Hallek M, Scheid C.
    Ann Hematol; 2010 Oct 01; 89(10):1029-33. PubMed ID: 20422413
    [Abstract] [Full Text] [Related]

  • 19. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection.
    Mak SK, Lo KY, Lo MW, Chan SF, Lo KC, Wong YY, Tong GM, Wong PN, Ma ES, Wong AK.
    Hong Kong Med J; 2009 Jun 01; 15(3):201-8. PubMed ID: 19494376
    [Abstract] [Full Text] [Related]

  • 20. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
    Schleinitz N, Ebbo M, Mazodier K, Poullin P, Bernit E, Veit V, Veyradier A, Fakhouri F, Kaplanski G, Harle JR.
    Am J Hematol; 2007 May 01; 82(5):417-8. PubMed ID: 17266057
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.